Morgan Stanley’s Exicure XCUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$672 Sell
158
-3,407
-96% -$15.7K ﹤0.01% 7566
2025
Q4
$19.3K Buy
3,565
+1,510
+73% +$7.36K ﹤0.01% 6704
2025
Q3
$8.4K Buy
2,055
+1,443
+236% +$8.69K ﹤0.01% 6947
2025
Q2
$4.31K Hold
612
﹤0.01% 7073
2025
Q1
$8.16K Sell
612
-4
-0.6% -$44 ﹤0.01% 6864
2024
Q4
$8.42K Sell
616
-29
-4% -$293 ﹤0.01% 6866
2024
Q3
$2.24K Buy
645
+31
+5% +$69 ﹤0.01% 7108
2024
Q2
$983 Sell
614
-3
-0.5% -$7 ﹤0.01% 7157
2024
Q1
$1.86K Sell
617
-691
-53% -$2.16K ﹤0.01% 7081
2023
Q4
$3.8K Buy
1,308
+635
+94% +$1.9K ﹤0.01% 7048
2023
Q3
$2.42K Sell
673
-5
-0.7% -$23 ﹤0.01% 7091
2023
Q2
$4.44K Hold
678
﹤0.01% 7012
2023
Q1
$2.95K Buy
678
+173
+34% +$1.06K ﹤0.01% 7164
2022
Q4
$2.9K Sell
505
-86
-15% -$532 ﹤0.01% 7278
2022
Q3
$5K Sell
591
-278
-32% -$2.6K ﹤0.01% 7260
2022
Q2
$9K Sell
869
-593
-41% -$12.5K ﹤0.01% 7253
2022
Q1
$43K Buy
1,462
+1,016
+228% +$31.2K ﹤0.01% 6782
2021
Q4
$13K Buy
446
+118
+36% +$13.7K ﹤0.01% 7391
2021
Q3
$59K Sell
328
-2
-0.6% -$405 ﹤0.01% 6644
2021
Q2
$74K Buy
330
+86
+35% +$22.5K ﹤0.01% 6482
2021
Q1
$81K Sell
244
-312
-56% -$107K ﹤0.01% 6121
2020
Q4
$147K Buy
556
+352
+173% +$88.1K ﹤0.01% 5743
2020
Q3
$54K Sell
204
-86
-30% -$28.1K ﹤0.01% 5698
2020
Q2
$106K Buy
290
+130
+81% +$47.1K ﹤0.01% 5376
2020
Q1
$36K Buy
160
+47
+42% +$14.9K ﹤0.01% 5585
2019
Q4
$49K Buy
113
+78
+223% +$31.9K ﹤0.01% 5865
2019
Q3
$14K Buy
+35
New +$13.4K ﹤0.01% 6114

Other funds holding XCUR

Morgan Stanley's XCUR Position: Q1 2026 in Review

Morgan Stanley reduced its Exicure (XCUR) stake by 96% in Q1 2026, selling an estimated $15.7K and leaving 158 shares worth $672. The position accounts for ﹤0.01% of the portfolio, ranked #7566.

Morgan Stanley first reported a position in XCUR in Q3 2019 and has held it in 27 quarters since. The position peaked at $147K in Q4 2020. 18 funds tracked by Wall St. Rank hold XCUR as of Q1 2026.

  • Morgan Stanley held 158 shares of Exicure worth $672 as of Q1 2026.
  • Morgan Stanley sold 3,407 Exicure shares in Q1 2026, an estimated $15.7K.
  • Exicure made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7566 holding.
  • Morgan Stanley first reported a position in Exicure in Q3 2019 and has held it in 27 quarters since.
  • Morgan Stanley's Exicure position peaked at $147K in Q4 2020.
  • 18 funds tracked by Wall St. Rank held Exicure as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.